Group One Trading’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.1K | Buy |
+4,963
| New | +$56.1K | ﹤0.01% | 1239 |
|
|
2025
Q1 | – | Sell |
-20,227
| Closed | -$171K | – | 2816 |
|
|
2024
Q4 | $171K | Buy |
20,227
+16,727
| +478% | +$142K | ﹤0.01% | 926 |
|
|
2024
Q3 | $40.5K | Buy |
+3,500
| New | +$40.5K | ﹤0.01% | 1050 |
|
|
2024
Q2 | – | Sell |
-414
| Closed | -$4.91K | – | 2469 |
|
|
2024
Q1 | $4.91K | Buy |
+414
| New | +$4.91K | ﹤0.01% | 1398 |
|
|
2023
Q4 | – | Sell |
-13,955
| Closed | -$134K | – | 2625 |
|
|
2023
Q3 | $134K | Buy |
13,955
+10,916
| +359% | +$105K | ﹤0.01% | 850 |
|
|
2023
Q2 | $27.4K | Buy |
+3,039
| New | +$27.4K | ﹤0.01% | 1151 |
|
|
2023
Q1 | – | Sell |
-897
| Closed | -$6.06K | – | 2546 |
|
|
2022
Q4 | $6.06K | Buy |
+897
| New | +$6.06K | ﹤0.01% | 1521 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2592 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2641 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2656 |
|
|
2021
Q4 | – | Sell |
-2,689
| Closed | -$47K | – | 2748 |
|
|
2021
Q3 | $47K | Buy |
2,689
+795
| +42% | +$13.9K | ﹤0.01% | 1551 |
|
|
2021
Q2 | $45K | Sell |
1,894
-1,275
| -40% | -$30.3K | ﹤0.01% | 1551 |
|
|
2021
Q1 | $81K | Buy |
3,169
+2,961
| +1,424% | +$75.7K | ﹤0.01% | 1250 |
|
|
2020
Q4 | $4K | Buy |
+208
| New | +$4K | ﹤0.01% | 1500 |
|